It all depends on you position i added to my position 5*orig. position yesterday. So if i can get 20% up im happy.
nah.. But A approval should set the floor at 12.. We should be at 9-10 though imho.. But all the spankings this has taken the last 6 months has done theirs..
I think 5% will not be enough at this point, if there are any results from the DTC campaigns it should start reflecting in the script #'s by now. With that said, i took a small position today and am betting that we see a bigger jump in scripts tomorrow to reverse this.
GSK already did that in anticipation of Vascepa. Thats a major reason why tier-2 inroads have been very fast, and should make scripts accelerate even faster going forward.
Its impossible to compete with a generic, thats true.. But ofcourse, generic lovaza is not generic Vascepa. They are different drugs. Generic statins hasn't kept branded statins from sellings for billions, why, because they have different labels, same indications, same type of drugs, but they have different profiles. Market is big enough for a generic Lovaza. Second, a generic lovaza will not have the price-differentiation of for example a statin. It's just more expensive to produce Lovaza than a few cents/pill statin. So they will compete with a price thats lower but not substantially lower, making it even more difficult to substantiate using a drug with a less favorable profile. Generic lovaza will prey on Lovaza primarily, whats left of it anyway as Vascepa is approved for Anchor.
One thing to also considder is this. If the FDA asks for reduce-it data, against what is agreed in the SPA, they better have a darn good reason for it. Because what they are doing then is saying, "we made you start a 100M$ trial" and then didn't honour our part of the agreement. What signal does that send to other companys they wan't to oblige to doing outcome-trials. The only valid reason i can see would be a major safety concern, and there is none
Sentiment: Strong Buy
Exactly. Find ONE drug with a safety profile as clean as Vascepa. Just look at the Qsymia and Belviq labels. After reading those you get genuinly scared!